nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advance directives in patients with advanced cancer receiving active treatment: attitudes, prevalence, and barriers
|
McDonald, Julie C. |
|
2016 |
25 |
2 |
p. 523-531 |
artikel |
2 |
An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer
|
Pinkerton, E |
|
2016 |
25 |
2 |
p. 341-343 |
artikel |
3 |
A qualitative exploration of oncology nurses’ family assessment practices in Denmark and Australia
|
Coyne, Elisabeth |
|
2016 |
25 |
2 |
p. 559-566 |
artikel |
4 |
A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer
|
Park, K. H. |
|
2016 |
25 |
2 |
p. 505-511 |
artikel |
5 |
A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation
|
Nakagaki, Midori |
|
2016 |
25 |
2 |
p. 607-613 |
artikel |
6 |
A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions
|
Elad, Sharon |
|
2016 |
25 |
2 |
p. 687-700 |
artikel |
7 |
Axillary web syndrome is not a risk factor for lymphoedema after 10 years of follow-up
|
Wariss, Bárbara Reis |
|
2016 |
25 |
2 |
p. 465-470 |
artikel |
8 |
Barriers to lung cancer care: health professionals’ perspectives
|
Dunn, J. |
|
2016 |
25 |
2 |
p. 497-504 |
artikel |
9 |
Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor
|
Weycker, Derek |
|
2016 |
25 |
2 |
p. 439-447 |
artikel |
10 |
Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study
|
Al-Dasooqi, Noor |
|
2016 |
25 |
2 |
p. 391-398 |
artikel |
11 |
Comparison of symptom clusters associated with fatigue in older and younger survivors of colorectal cancer
|
Agasi-Idenburg, S. C. |
|
2016 |
25 |
2 |
p. 625-632 |
artikel |
12 |
Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?
|
Fusco, Vittorio |
|
2016 |
25 |
2 |
p. 345-349 |
artikel |
13 |
Dermatologic events from EGFR inhibitors: the issue of the missing patient voice
|
Tischer, Bernd |
|
2016 |
25 |
2 |
p. 651-660 |
artikel |
14 |
Determining best methods to screen for religious/spiritual distress
|
King, Stephen D. W. |
|
2016 |
25 |
2 |
p. 471-479 |
artikel |
15 |
Discrepancy between long-term and previously published analysis for osteonecrosis of the jaw under denosumab
|
de Boissieu, Paul |
|
2016 |
25 |
2 |
p. 351-352 |
artikel |
16 |
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer
|
Liang, Yi-Hsin |
|
2016 |
25 |
2 |
p. 533-539 |
artikel |
17 |
Do-not-resuscitate orders in cancer patients: a review of literature
|
Osinski, Aart |
|
2016 |
25 |
2 |
p. 677-685 |
artikel |
18 |
Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin–cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study
|
Thamlikitkul, Lucksamon |
|
2016 |
25 |
2 |
p. 459-464 |
artikel |
19 |
Evaluation of the effects and adverse drug reactions of low-dose dexamethasone premedication with weekly docetaxel
|
Kang, Rae Young |
|
2016 |
25 |
2 |
p. 429-437 |
artikel |
20 |
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia
|
Sands, Stephen A. |
|
2016 |
25 |
2 |
p. 449-457 |
artikel |
21 |
Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?
|
Brice, Lisa |
|
2016 |
25 |
2 |
p. 421-427 |
artikel |
22 |
Health-related problems in adult cancer survivors: development and validation of the Cancer Survivor Core Set
|
Geerse, O.P. |
|
2016 |
25 |
2 |
p. 567-574 |
artikel |
23 |
Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia
|
Ganti, Beejal R. |
|
2016 |
25 |
2 |
p. 541-547 |
artikel |
24 |
Impact of enhanced recovery program on patients with esophageal cancer in comparison with traditional care
|
Wang, Lihong |
|
2016 |
25 |
2 |
p. 381-389 |
artikel |
25 |
Lost and stranded: the experience of younger adults with advanced cancer
|
Knox, Matthew K. |
|
2016 |
25 |
2 |
p. 399-407 |
artikel |
26 |
Palliative care consultation team on acute wards—an intervention study with pre-post comparisons
|
Friedrichsen, Maria |
|
2016 |
25 |
2 |
p. 371-380 |
artikel |
27 |
Pathways between physical activity and quality of life in African-American breast cancer survivors
|
Meadows, Rachel |
|
2016 |
25 |
2 |
p. 489-495 |
artikel |
28 |
Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications
|
Stefanovic, Stefan |
|
2016 |
25 |
2 |
p. 549-558 |
artikel |
29 |
Photobiomodulation therapy in the management of chronic oral graft-versus-host disease
|
Epstein, Joel B. |
|
2016 |
25 |
2 |
p. 357-364 |
artikel |
30 |
Preliminary evaluation of a predictive blood assay to identify patients at high risk of chemotherapy-induced nausea
|
Kutner, Thomas |
|
2016 |
25 |
2 |
p. 581-587 |
artikel |
31 |
Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity
|
Saito, Yoshitaka |
|
2016 |
25 |
2 |
p. 481-487 |
artikel |
32 |
Psychometric properties and measurement equivalence of the English and Chinese versions of the Beck Anxiety Inventory in patients with breast cancer
|
Ke, Yu |
|
2016 |
25 |
2 |
p. 633-643 |
artikel |
33 |
Quality of life (QOL) and symptom burden (SB) in patients with breast cancer
|
Hamer, Julia |
|
2016 |
25 |
2 |
p. 409-419 |
artikel |
34 |
Quality of life trajectories after diagnosis of gynecologic cancer: a theoretically based approach
|
Gonzalez, Brian D. |
|
2016 |
25 |
2 |
p. 589-598 |
artikel |
35 |
Response to letter to the Editors—Safety of long-term denosumab therapy
|
Stopeck, Alison T. |
|
2016 |
25 |
2 |
p. 353-355 |
artikel |
36 |
Risk factors for same-admission mortality after pathologic fracture secondary to metastatic cancer
|
Behnke, Nicole K. |
|
2016 |
25 |
2 |
p. 513-521 |
artikel |
37 |
The Enhancing Connections-Telephone study: a pilot feasibility test of a cancer parenting program
|
Lewis, Frances Marcus |
|
2016 |
25 |
2 |
p. 615-623 |
artikel |
38 |
The impact of a simplified documentation method for the Edmonton classification system for cancer pain (ECS-CP) on clinician utilization
|
Tanco, Kimberson |
|
2016 |
25 |
2 |
p. 575-580 |
artikel |
39 |
The role of palliative care in the last month of life in elderly cancer patients
|
Assi, Tarek |
|
2016 |
25 |
2 |
p. 599-605 |
artikel |
40 |
The use of low doses of a sublingual fentanyl formulation for breakthrough pain in patients receiving low doses of opioids
|
Mercadante, Sebastiano |
|
2016 |
25 |
2 |
p. 645-649 |
artikel |
41 |
The use of opioids in cancer patients with renal impairment—a systematic review
|
Sande, Tonje A. |
|
2016 |
25 |
2 |
p. 661-675 |
artikel |
42 |
Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials
|
Roeland, Eric J. |
|
2016 |
25 |
2 |
p. 365-369 |
artikel |